Mode
Text Size
Log in / Sign up
N/A N=67 Prevention

Liver Cancer Community Education

Liver Cancer

Enrolled (actual)
67
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Change in Mean Liver Cancer Knowledge — 1.26 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
LIVE-R Life Education (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Fox Chase Cancer Center
Primary completion
Apr 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Mean Liver Cancer Knowledge
1.26
PRIMARY
Change in General Interest in Learning About Neighborhood Health
-1.81
PRIMARY
Change in Interest in Learning About Neighborhood Health From a Healthcare Provider
-0.95
PRIMARY
Change in Interest in Learning About Neighborhood Health From Other Sources
-0.90
PRIMARY
Change in Interest in Discussing High Liver Cancer Risk With a Healthcare Provider
-1.58
PRIMARY
Change in Outcome Expectancies for Learning About Neighborhood Health - Patient Behavior
0.83
PRIMARY
Change in Outcome Expectancies for Learning About Neighborhood Health - Provider Behavior
-0.77
PRIMARY
Change in Intentions About Communicating With Healthcare Provider - Neighborhood Prevalence of Liver Cancer
0.79
PRIMARY
Change in Intentions About Communicating With Healthcare Provider - Liver Cancer Screening
0.67
PRIMARY
Change in Intentions About Communicating With Healthcare Provider - Liver Cancer Risk
0.35

Summary

This study proposes to bridge the gap between evidence and action and combat rising liver cancer rates attributed to Hepatitis B and C infection in Philadelphia by identifying neighborhoods with higher than expected rates of liver cancer and related risk factors and administering an educational intervention about liver cancer and neighborhood health in those communities, working with existing community partners at Fox Chase Cancer Center.

Eligibility Criteria

Inclusion Criteria

  • Speaks/reads English
  • Lives in Philadelphia or receives healthcare at a community partner site in Philadelphia

Exclusion Criteria

  • None
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04272619). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search